Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 701–704 of 704 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04515602	Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)	not yet recruiting	Phase 3	410	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Aug 27, 2020	clinicaltrials
NCT04227249	3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer(TREE PRO)	not yet recruiting	—	153	Seoul National University HospitalOTHER	0	Jan 14, 2020